The Zr(IV) mixed-linker metal-organic framework (MIXMOF) [Zr6O4(OH)7(H2O)3(TPDC)3(BTDZ)1.5] [Zr_BTDZ; H2TPDC = (p-terphenyl)-4,4′′-dicarboxylic acid, H2BTDZ = 4,4′-(benzothiadiazole-4,7-diyl)dibenzoic acid], exhibiting an UiO-68-type crystal structure, was prepared through direct synthesis under solvothermal conditions. Zr_BTDZ is fully microporous, with pore sizes in the range of 18 ≤ w ≤ 22 Å and a BET SSA of 3770 m2 g−1. The benzothiadiazole ring imparts luminescence to the material, showing a very intense ligand-centered emission band at λmax = 516 nm (upon UV excitation at λ = 328 nm) falling in the light green visible region. Zr_BTDZ was exploited as a luminescent sensor and an adsorbent of the pharmaceuticals diclofenac sodium (DCF) and ibuprofen sodium (IBR) in aqueous solutions. No λmax variation occurs upon interaction with the drugs; while for DCF an emission intensity decrease is observed with increasing pollutant concentration in solution, the opposite holds for IBR. The limit of detection is 4.1 × 10−6 and 1.6 × 10−6 M for DCF and IBR, respectively, while the maximum adsorption capacity at ambient temperature (Xm) is 100 and 161 mg g−1 for DCF and IBR, respectively. The non-covalent host-guest interactions were disclosed through DFT optimizations of the [DCF@Zr_BTDZ] and [IBR@Zr_BTDZ] adducts; hydrogen bonding between the μ-OH groups of the [Zr6] inorganic building unit and the DCF/IBR carboxylate groups occurs, together with π-π T-shaped/π-cation interactions between the aromatic rings/Na+ ion of IBR/DCF and the MOF organic linkers. The calculated adduct formation energies [ΔE(DCF) = −192.5 kJ mol−1; ΔE(IBR) = −228.2 kJ mol−1] are in line with the experimentally derived binding constants [Kb(DCF) = 12.6 × 104 M−1; Kb(IBR) = 14.9 × 104 M−1], showing a stronger interaction with IBR.
A benzothiadiazole-decorated UiO-68 metal–organic framework for diclofenac and ibuprofen luminescence sensing and adsorption in wastewater
Mauri, Anna;Galli, Simona;
2025-01-01
Abstract
The Zr(IV) mixed-linker metal-organic framework (MIXMOF) [Zr6O4(OH)7(H2O)3(TPDC)3(BTDZ)1.5] [Zr_BTDZ; H2TPDC = (p-terphenyl)-4,4′′-dicarboxylic acid, H2BTDZ = 4,4′-(benzothiadiazole-4,7-diyl)dibenzoic acid], exhibiting an UiO-68-type crystal structure, was prepared through direct synthesis under solvothermal conditions. Zr_BTDZ is fully microporous, with pore sizes in the range of 18 ≤ w ≤ 22 Å and a BET SSA of 3770 m2 g−1. The benzothiadiazole ring imparts luminescence to the material, showing a very intense ligand-centered emission band at λmax = 516 nm (upon UV excitation at λ = 328 nm) falling in the light green visible region. Zr_BTDZ was exploited as a luminescent sensor and an adsorbent of the pharmaceuticals diclofenac sodium (DCF) and ibuprofen sodium (IBR) in aqueous solutions. No λmax variation occurs upon interaction with the drugs; while for DCF an emission intensity decrease is observed with increasing pollutant concentration in solution, the opposite holds for IBR. The limit of detection is 4.1 × 10−6 and 1.6 × 10−6 M for DCF and IBR, respectively, while the maximum adsorption capacity at ambient temperature (Xm) is 100 and 161 mg g−1 for DCF and IBR, respectively. The non-covalent host-guest interactions were disclosed through DFT optimizations of the [DCF@Zr_BTDZ] and [IBR@Zr_BTDZ] adducts; hydrogen bonding between the μ-OH groups of the [Zr6] inorganic building unit and the DCF/IBR carboxylate groups occurs, together with π-π T-shaped/π-cation interactions between the aromatic rings/Na+ ion of IBR/DCF and the MOF organic linkers. The calculated adduct formation energies [ΔE(DCF) = −192.5 kJ mol−1; ΔE(IBR) = −228.2 kJ mol−1] are in line with the experimentally derived binding constants [Kb(DCF) = 12.6 × 104 M−1; Kb(IBR) = 14.9 × 104 M−1], showing a stronger interaction with IBR.| File | Dimensione | Formato | |
|---|---|---|---|
|
142_JphysChemC_2025_13_16427.pdf
accesso aperto
Tipologia:
Versione Editoriale (PDF)
Licenza:
Creative commons
Dimensione
3.08 MB
Formato
Adobe PDF
|
3.08 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.



